Takeaway
- In patients with CD30+ relapsed/refractory lymphomas, infusions of preactivated cord blood (CB)-derived natural killer (NK) cells complexed with AFM13, a bispecific antibody that binds CD16A on NK cells and CD30 on lymphoma cells, are safe.
- The approach showed early efficacy and warrants further investigation.
Why this matters
- CB-derived NK...